KZR Message Board Post 10946982 | Kezar Life Sciences Inc.
home / stock / kzr / kzr message board
MarketWireNews
(investorshangout)
Posted on: Nov/17/2021 02:20:47
Source: investorshangout
https://investorshangout.com/post/view?id=6284831
znewcar1: KZR 37% v33M c11.59 f49,1M preMH16 S10.4
News, Short Squeeze, Breakout and More Instantly...
-
Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer, today announced that Chris Kirk, Co-founder and Chief Executive Officer, will participate in a fireside chat at...
-
PALIZADE Phase 2b clinical trial of zetomipzomib in patients with active lupus nephritis actively enrolling; reiterating guidance of topline data in mid-2026 PORTOLA Phase 2a clinical trial of zetomipzomib in patients with autoimmune hepatitis actively enrolling; reiterating guidance of t...
-
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...